Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)

Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y) Publisher

Azimi M¹ ; Sepehrmansourie H² ; Ebadi A^{1, 3} ; Chehardoli G^{1, 3} ; Zolfigol MA⁴ ; Amanlou M⁵ ; Nazari Montazer M⁵ ; Mahdavi M⁶ ; Najafi Z^{1, 3}

Source: Medicinal Chemistry Research Published:2025

Abstract

Correction to: Medicinal Chemistry Research (2025) 34:675-689; https://doi.org/10.1007/s00044-024-03369-y, published online 13 January 2025 In PDF version of this article, Scheme 1 was inadvertently cropped at the bottom. The correct Scheme 1 is given below. (Figure presented.) The original article has been corrected. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025.

2. Author Correction: Magnetic Nh2-Mil-101(Al)/Chitosan Nanocomposite As a Novel Adsorbent for the Removal of Azithromycin: Modeling and Process Optimization (Scientific Reports, (2022), 12, 1, (18990), 10.1038/S41598-022-21551-3), Scientific Reports (2023)

3. Correction To: Promising Antibacterial Effects of Silver Nanoparticle-Loaded Tea Tree Oil Nanoemulsion: A Synergistic Combination Against Resistance Threat (Aaps Pharmscitech, (2017), 10.1208/S12249-017-0922-Y), AAPS PharmSciTech (2018)

Experts (# of related papers)

View all Related Experts

Nabi Shariatifar (2)

Sharmin Kharrazi (1)

Style	Citing Format
MLA	Azimi M, et al.. "Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)." Medicinal Chemistry Research, vol. 34, no. 5, 2025, pp. 1144-.
APA	Azimi M, Sepehrmansourie H, Ebadi A, Chehardoli G, Zolfigol MA, Amanlou M, Nazari Montazer M, Mahdavi M, Najafi Z (2025). Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y). Medicinal Chemistry Research, 34(5), 1144-.
Chicago	Azimi M, Sepehrmansourie H, Ebadi A, Chehardoli G, Zolfigol MA, Amanlou M, Nazari Montazer M, Mahdavi M, Najafi Z. "Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)." Medicinal Chemistry Research 34, no. 5 (2025): 1144-.
Harvard	Azimi M et al. (2025) 'Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)', Medicinal Chemistry Research, 34(5), pp. 1144-.
Vancouver	Azimi M, Sepehrmansourie H, Ebadi A, Chehardoli G, Zolfigol MA, Amanlou M, et al.. Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y). Medicinal Chemistry Research. 2025;34(5):1144-.
BibTex	@article{ author = {Azimi M and Sepehrmansourie H and Ebadi A and Chehardoli G and Zolfigol MA and Amanlou M and Nazari Montazer M and Mahdavi M and Najafi Z}, title = {Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)}, journal = {Medicinal Chemistry Research}, volume = {34}, number = {5}, pages = {1144-}, year = {2025} }
RIS	TY - JOUR AU - Azimi M AU - Sepehrmansourie H AU - Ebadi A AU - Chehardoli G AU - Zolfigol MA AU - Amanlou M AU - Nazari Montazer M AU - Mahdavi M AU - Najafi Z TI - Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y) JO - Medicinal Chemistry Research VL - 34 IS - 5 SP - 1144 EP - PY - 2025 ER -

Style

Citing Format

MLA

Azimi M, et al.. "Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)." Medicinal Chemistry Research, vol. 34, no. 5, 2025, pp. 1144-.

APA

Azimi M, Sepehrmansourie H, Ebadi A, Chehardoli G, Zolfigol MA, Amanlou M, Nazari Montazer M, Mahdavi M, Najafi Z (2025). Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y). Medicinal Chemistry Research, 34(5), 1144-.

Chicago

Azimi M, Sepehrmansourie H, Ebadi A, Chehardoli G, Zolfigol MA, Amanlou M, Nazari Montazer M, Mahdavi M, Najafi Z. "Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)." Medicinal Chemistry Research 34, no. 5 (2025): 1144-.

Harvard

Azimi M et al. (2025) 'Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)', Medicinal Chemistry Research, 34(5), pp. 1144-.

Vancouver

Azimi M, Sepehrmansourie H, Ebadi A, Chehardoli G, Zolfigol MA, Amanlou M, et al.. Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y). Medicinal Chemistry Research. 2025;34(5):1144-.

BibTex

@article{ author = {Azimi M and Sepehrmansourie H and Ebadi A and Chehardoli G and Zolfigol MA and Amanlou M and Nazari Montazer M and Mahdavi M and Najafi Z}, title = {Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)}, journal = {Medicinal Chemistry Research}, volume = {34}, number = {5}, pages = {1144-}, year = {2025} }

RIS

TY - JOUR
AU - Azimi M
AU - Sepehrmansourie H
AU - Ebadi A
AU - Chehardoli G
AU - Zolfigol MA
AU - Amanlou M
AU - Nazari Montazer M
AU - Mahdavi M
AU - Najafi Z
TI - Correction To: Design, Synthesis, in Vitro Evaluation, and Molecular Dynamics Simulation Studies of Novel Coumarin-Acetohydrazide Schiff Base Derivatives As Urease Enzyme Inhibitors (Medicinal Chemistry Research, (2025), 34, 3, (675-689), 10.1007/S00044-024-03369-Y)
JO - Medicinal Chemistry Research
VL - 34
IS - 5
SP - 1144
EP -
PY - 2025
ER -

Science Communicator Platform

Authors

Abstract